You are now leaving www.FRX.com

Thank you for visiting www.FRX.com. You are now being redirected to an external site.

Important Definitions and Methodology

  • Please take the time to review and understand the definitions and methodology used in preparing our Disclosure Reports.
  • Forest has strived to create accurate reports by ensuring that our employees and vendors collect all relevant data and attribute payments accurately and consistently. Please note that due to occasional delays in reconciliation for certain indirect payments, some payments or transfers of value may not be included until a later reporting period, and some payments or transfers of value may be reclassified upon receipt of additional information. We will periodically update our Disclosure Reports as necessary. If you have a specific inquiry about a particular posted payment, please contact DisclosureReportInquiry@frx.com.
  • What are Forest's Disclosure Reports?
    The Disclosure Report contains a listing of U.S.-based physicians and related entities who received certain types of payments or transfers of value directly or indirectly from Forest during a defined time period. The Clinical Research Disclosure Report contains a listing of U.S.-based research institutions and entities, hospitals, and physicians who received payments in connection with Forest-sponsored clinical research during a defined period.
  • What Information is Included in the Disclosure Report?
    The Disclosure Report contains information about the name of the physician who received a relevant payment or transfer of value; the name of a related entity, if applicable; the amount of the payment or transfer of value reported; the city/state associated with the physician's license on record; and the purpose of the payment or transfer of value.
  • What is a Related Entity?
    Pursuant to Forest's Corporate Integrity Agreement, payments to related entities (defined as an entity by or in which a physician is employed, has tenure, or has an ownership interest) are reported when the payment is made to the entity on behalf of, at the request of, for the benefit or use of, or under the name of a physician for whom Forest would otherwise report a payment if made directly to the physician.
  • What types of payments and transfers of value are included in the report?
    The Disclosure Report includes payments or transfers of value greater than or equal to $10.00, or where the aggregate amount paid to an individual physician is greater than $100.00 per year, all payments or transfers of value to an individual physician.

    The following types of payments and transfers of value may be included in the Disclosure Report:

    Consulting Fees: Fees paid to physicians in compensation for providing bona fide consulting services to Forest. Forest's consulting engagements with healthcare professionals are critical to advancing scientific knowledge and research, and to developing more effective therapies. Consulting services may be provided on an individual basis or through participation in advisory boards or roundtables. Consultants enter into a contracted consulting engagement and are paid a fair market value rate.

    Speaking Fees: Fees paid to a physician in compensation for services rendered in connection with presentations at Forest-sponsored peer-to-peer educational programs. Forest believes educational exchanges among peers are critical in disseminating accurate information about our products and improving patient care. Physicians who perform speaking services are compensated at a fair market value rate. Peer-to-peer educational programs sponsored by Forest are promotional in nature and are governed by FDA laws and regulations.

    Business Travel Expenses: Costs incurred and expenses paid in connection with business travel by physicians serving as consultants or speakers for Forest, including transportation and lodging. Pursuant to Forest policy, any travel expenses incurred by a consultant or speaker must be reasonable in nature and properly documented.

    Educational Items: Items designed primarily for the education of patients or healthcare professionals that comply with the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (the "PhRMA Code"). Such items are not of substantial value and are not intended to have value to healthcare professionals outside of their professional responsibilities.

    Meals: The estimated value of food or snacks provided to a physician in connection with an educational exchange or presentation relating to Forest products. Forest occasionally provides modest meals and snacks during educational interactions relating to its products in recognition of the fact that physicians have busy schedules that require them to balance patient care and other responsibilities. Pursuant to Forest policy, such food items are provided consistent with the principles in the PhRMA Code. Estimated dollar values for meals are typically calculated by dividing the overall cost of the meal by the number of attendees or participants. The per-capita amount included in the Disclosure Report may or may not be representative of an individual physician's actual consumption.

    This category also captures meal costs and expense reimbursements for food consumed by healthcare professionals while performing their duties as a consultant or speaker for Forest. As a result, the reported amount for a particular physician may in some instances reflect both food consumed as an attendee at a Forest-sponsored educational program and food consumed by a consultant or speaker in the course of performing services for Forest.

    Research: Funding that supports a physician's independent research intended to expand scientific knowledge relating to an FDA-approved drug or Forest-initiated clinical research. Independent research proposals are unsolicited by Forest and derived from the academic research interests or clinical experience of independent investigators.

  • What time periods are covered in the Disclosure Report?
    Forest posts quarterly Disclosure Reports for relevant payments and transfers of value within 60 days following the end of each calendar quarter and an annual Disclosure Report within 60 days following the end of a calendar year.
  • What Information is Included in the Clinical Research Disclosure Report?
    The Clinical Research Disclosure Report lists research institutions and entities, hospitals, and physicians who received payments in connection with Forest-sponsored clinical research; the name of the associated principal investigator, if applicable; the amount of the payment; and the city/state associated with the payee's address. For each payment included on the Clinical Research Report, Forest has included the name of the Principal Investigator (PI) associated with the research. Please note, the inclusion of a PI's name in connection with a particular payment does not mean that the PI necessarily received any or all of the payment or transfer of value. In many cases, some or all of the payment may have been used by the payee to support payments to other healthcare professionals working on the research.
  • What time periods are covered in the Clinical Research Disclosure Report?
    Forest posts quarterly Clinical Research Disclosure Reports for relevant payments and transfers of value within 60 days following the end of each calendar quarter and an annual Disclosure Report within 60 days following the end of a calendar year.

Click here to access Forest's Q1 2013 Disclosure Report
Click here to access Forest's 2012 Annual Disclosure Report

Click here to access Forest's Q1 2013 Clinical Research Disclosure Report
Click here to access Forest's 2012 Annual Clinical Research Disclosure Report

Forest Laboratories
Divisions and Subsidiaries
  • Forest Pharmaceuticals
  • Forest Laboratories Europe
  • Cerexa, Inc.
  • Forest Laboratories Canada Inc.
  • About Forest
        • Overview
          • Forest identifies, develops, and delivers treatments that make a meaningful difference in people's lives
        • Products
        • Research
        • News
  • Investor Center
        • Overview
          • Forest is building on a strong track record of commercial achievement to deliver important new medicines and strengthen our therapeutic franchises
        • Annual Reports
        • Stock Information
        • Webcasts &
          Presentations
  • Partnerships
        • Overview
          • Forest partners with biotech and pharmaceutical companies around the world to develop and bring promising new medicines to market
        • Capabilities
  • Careers
        • Overview
          • Joining Forest is an opportunity to become part of a forward-thinking community dedicated to helping improve patients' lives through medicine
        • Job Search
  • About Forest
  • Products
    • Authorized Distributors
    • Anti-Infective
      • MONUROL®
      • TEFLARO®
    • Cardiovascular
      • BYSTOLIC®
      • TIAZAC®
    • Central Nervous System
      • CAMPRAL®
      • CELEXA®
      • LEXAPRO®
      • NAMENDA®
      • NAMENDA XR™
      • VIIBRYD®
    • Endocrinology
      • ARMOUR® THYROID
      • LEVOTHROID®
      • THYROLAR®
    • Gastrointestinal
      • LINZESS®
    • Obstetrics
      • CERVIDIL®
    • Pain Management
      • SAVELLA®
    • Respiratory
      • AEROCHAMBER PLUS®
        FLOW-VU®
      • DALIRESP®
      • TUDORZA® PRESSAIR®
  • Research
  • News

LEXAPRO®

Lexapro

Prescribing Information

Download the LEXAPRO full Prescribing Information, including Boxed Warning

About Forest

With a unique partnership-focused business model and a strong track record of commercial achievement, Forest has built a pharmaceutical business for today's environment. The Company is fulfilling its objective of making a meaningful difference in patients' lives through an expanded and diversified product portfolio and the most robust pipeline in our history.

Careers at Forest

Forest employees are driven by a shared passion to help improve patients' lives through medicine. Forest offers a variety of opportunities for experienced professionals, sales professionals, graduate students, and others to build their careers in a collaborative environment. Learn more about joining our team.

 

  • Legal Statement
  • Privacy Policy
  • Contact Us
  • Site Map
© 2013 Forest Laboratories, Inc.    085-13000018 06/13